CNS Pharmaceuticals, Inc.

NEWS

Image of Houston downtown park and skyline in the morning

Business

Houston’s Life Sciences Scene Continues Boosting Its Reputation

While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.

March 13, 2025

6 min read

Angela Gabriel

IN THE PRESS

Lone Star Bio

Over 100 Patients Now Enrolled in CNS Pharmaceuticals’ (NASDAQ: CNSP) Potentially Pivotal Study Evaluating Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

April 10, 2023

7 min read

Lone Star Bio

CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

April 6, 2023

6 min read

Business

CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update

April 3, 2023

7 min read

Lone Star Bio

CNS Pharmaceuticals to Present at the Virtual Investor GBM Spotlight Event

March 29, 2023

2 min read

Lone Star Bio

CNS Pharmaceuticals Announces it Has No Exposure to Silicon Valley Bank Issues

March 13, 2023

1 min read

Lone Star Bio

CNS Pharmaceuticals Continues Momentum in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM with First Patient Enrolled in Switzerland

March 9, 2023

6 min read

Lone Star Bio

CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

February 7, 2023

6 min read

Drug Development

CNS Pharmaceuticals Announces Investigator-Initiated Phase 1b/2 Trial to be Conducted at the Pomeranian Medical University in Poland

January 12, 2023

6 min read

Lone Star Bio

CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event

January 5, 2023

1 min read

Business

CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors

January 3, 2023

5 min read

JOBS